Erin Pennock Foff
Chief Medical Officer at MapLight Therapeutics, Inc. (MPLT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 7,155338,904 held (−2%) | $36.16 | $259K | -75.6% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 7,845331,059 held (−2%) | $37.04 | $291K | -76.2% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 4,465326,594 held (−1%) | $36.00 | $161K | -75.5% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 8,972317,622 held (−3%) | $36.99 | $332K | -76.1% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 18317,604 held (−0%) | $37.54 | $676 | -76.5% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 9,163308,441 held (−3%) | $36.46 | $334K | -75.8% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 5,865302,576 held (−2%) | $37.26 | $219K | -76.3% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 19302,557 held (−0%) | $37.96 | $721 | -76.7% |
| Jul 17SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 3,656298,901 held (−1%) | $37.90 | $139K | -76.7% |
| May 11SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 4,321346,176 held (−1%) | $28.52 | $123K | -69.0% |
| May 11SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 117346,059 held (−0%) | $29.10 | $3K | -69.7% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 9,180391,597 held (−2%) | $27.50 | $252K | -67.9% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 5,460386,137 held (−1%) | $28.37 | $155K | -68.9% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 312385,825 held (−0%) | $29.56 | $9K | -70.1% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 700385,125 held (−0%) | $30.08 | $21K | -70.6% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 9,645375,480 held (−3%) | $28.12 | $271K | -68.6% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 931374,549 held (−0%) | $29.00 | $27K | -69.6% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 8,152366,397 held (−2%) | $28.04 | $229K | -68.5% |
| May 6SEC | MPLTMapLight Therapeutics, Inc. | Sell Plan | 15,900350,497 held (−4%) | $29.13 | $463K | -69.7% |
| Apr 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 2,044401,946 held (−1%) | $26.84 | $55K | -67.1% |
| Apr 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 288401,658 held (−0%) | $27.01 | $8K | -67.3% |
| Apr 17SEC | MPLTMapLight Therapeutics, Inc. | Sell | 881400,777 held (−0%) | $27.49 | $24K | -67.9% |
- Sell
Chief Medical Officer Erin Pennock Foff sold $259K of MPLT at $36.16 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Erin Pennock Foff sold $291K of MPLT at $37.04 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Erin Pennock Foff sold $161K of MPLT at $36.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Erin Pennock Foff sold $332K of MPLT at $36.99 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Erin Pennock Foff sold $676 of MPLT at $37.54 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Erin Pennock Foff sold $334K of MPLT at $36.46 — pre-scheduled 10b5-1 plan sale.